Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-23

FDA Approved: PREVDUO — Original Application (Endo USA)

View source ↗

Summary

The FDA approved PREVDUO, a fixed-dose combination of neostigmine methylsulfate and glycopyrrolate, under an original NDA for reversal of neuromuscular blockade…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREVDUO (NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE)

Snippet

ORIG AP for PREVDUO (NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE)